NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 19.00
0.00 (0.00%)
May 8, 2026, 1:53 PM CST
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 893.05 million as of May 8, 2026. Its market cap has decreased by -10.36% in one year.
Market Cap
893.05M
Enterprise Value
450.58M
Revenue
176.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.00
Market Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 893.05M, an increase of 212.34%. That is a compound annual growth rate of 6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 893.05M | -8.43% |
| Dec 31, 2025 | 975.30M | -20.71% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.11B |
| Level Biotechnology | 1.10B |
| LabTurbo Biotech | 1.06B |
| GeneReach Biotechnology | 1.06B |
| Lukas Biomedical | 1.06B |
| U-Neuron Biomedical | 1.04B |
| Taiwan Advance Bio-Pharmaceutical | 967.50M |
| TCI GENE | 952.51M |